TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32233962

Group type: EXPERIMENTAL
Intervention: Obstetrician-gynecologists retrieving medication safety information during clinical visits
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Provision of potentially problematic 'safe lists' to patients
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Limited counseling for reproductive-aged patients not actively planning a pregnancy
Number of subjects: 506
Study: 32843260

Group type: EXPERIMENTAL
Intervention: Music pedagogical program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study: 33975736

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum uric acid levels
Number of subjects: 15666
Study: 32856734

Group type: EXPERIMENTAL
Intervention: RBC units stored not more than 7 days
Number of subjects: 2510

Group type: COMPARATOR
Intervention: Oldest compatible RBC units
Number of subjects: 2510
Study: 33641634

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sucralose
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Steviol glycosides
Number of subjects: 39
Study: 33323057

Group type: EXPERIMENTAL
Intervention: Balloon-assisted maturation (BAM) technique
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard technique (NO BAM)
Number of subjects: 300
Study: 33010968

Group type: EXPERIMENTAL
Intervention: Multimodal pelvic floor physical therapy (12 weekly 60‐min sessions)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Multimodal pelvic floor physical therapy
Number of subjects: 31
Study: 35045852

Group type: EXPERIMENTAL
Intervention: Question-answer format
Number of subjects: 2215

Group type: EXPERIMENTAL
Intervention: Fact-only format
Number of subjects: 2215

Group type: EXPERIMENTAL
Intervention: Fact-myth format
Number of subjects: 2215
Study: 33873195

Group type: EXPERIMENTAL
Intervention: Caring mindfulness-based approach for seniors (CMBAS)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Health self-management program (HSMP)
Number of subjects: 147
Study: 32987839

Group type: EXPERIMENTAL
Intervention: Rice-based meals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Meals with other cereals
Number of subjects: 60
Study: 35236752

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node mapping without systematic lymphadenectomy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Sentinel lymph node mapping with systematic pelvic and para-aortic lymphadenectomy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Sentinel lymph node mapping with systematic lymphadenectomy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node mapping ± systematic lymphadenectomy
Number of subjects: 178
Study: 32867593

Group type: EXPERIMENTAL
Intervention: Smartphone app exposure (50-MF, 100-MF, 200-MF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (without smartphone app exposure) (50-CON, 100-CON, 200-CON)
Number of subjects: 25
Study: 34311999

Group type: EXPERIMENTAL
Intervention: Return to diet at 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Return to diet at 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Return to diet at 6 weeks (control group)
Number of subjects: 0
Study: 35312632

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33117131

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: No-stim control treatment
Number of subjects: 34
Study: 33567218

Group type: EXPERIMENTAL
Intervention: Violet light-emitting diodes (LEDs) device emitting violet light (405-410 nm) without peroxide-containing bleaching gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: 35% hydrogen peroxide gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both whitening protocols (Violet LED and 35% hydrogen peroxide)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Violet light alone
Number of subjects: 60
Study: 32950853

Group type: EXPERIMENTAL
Intervention: Elastic touch-display
Number of subjects: 22

Group type: COMPARATOR
Intervention: Tambourines
Number of subjects: 22
Study: 35346348

Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention delivered regularly for 12 months
Number of subjects: 376

Group type: COMPARATOR
Intervention: Treatment as usual + DIALOG scale
Number of subjects: 376
Study: 33450192

Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGGs) from the palate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Porcine collagen matrix (mucoderm)
Number of subjects: 18
Study: 32311204

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 813

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 813
Study: 34520841

Group type: EXPERIMENTAL
Intervention: Pars Plana Vitrectomy (PPV)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Pneumatic Retinopexy (PnR)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PPV with ORFs
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PPV without ORFs
Number of subjects: 88

Group type: COMPARATOR
Intervention: PnR without ORFs
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overall with ORFs
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overall without ORFs
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Horizontal metamorphopsia
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Vertical metamorphopsia
Number of subjects: 88
Study: 32892272

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 1381

Group type: COMPARATOR
Intervention: Other studies
Number of subjects: 1381
Study: 36463165

Group type: EXPERIMENTAL
Intervention: ACLR using hamstring tendon autograft
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ACLR using artificial LARS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ACLR performed within 1 year of injury
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ACLR performed more than 1 year after injury
Number of subjects: 40
Study: 32478863

Group type: EXPERIMENTAL
Intervention: 98% cannabidiol in oil (Tilray, Canada)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 35702866

Group type: EXPERIMENTAL
Intervention: Chlorhexidine body wash, chlorhexidine mouthwash, and nasal mupirocin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothetical therapy improvements in silico
Number of subjects: 0
Study: 34269387

Group type: EXPERIMENTAL
Intervention: Mobile health technologies for behavior change and self-care
Number of subjects: 0
Study: 32119928

Group type: EXPERIMENTAL
Intervention: HUNT tool
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: M-BERET tool
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: Kunzmann tool
Number of subjects: 1241

Group type: COMPARATOR
Intervention: Gastroesophageal reflux disease (GERD) symptoms alone
Number of subjects: 1241

Group type: COMPARATOR
Intervention: Frequency and duration of GERD
Number of subjects: 1241

Group type: COMPARATOR
Intervention: All tools compared to GERD
Number of subjects: 1241
Study: 33037726

Group type: EXPERIMENTAL
Intervention: Nifekalant 0.4 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifekalant 0.5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifekalant 0.3 mg/kg
Number of subjects: 0
Study: 37032583

Group type: EXPERIMENTAL
Intervention: Active nVNS device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 40
Study: 34886327

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Future Thinking Priming (FTP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 20
Study: 32594922

Group type: EXPERIMENTAL
Intervention: Highest quintile of gestational weight gain (GWG) rate
Number of subjects: 13765

Group type: COMPARATOR
Intervention: Middle quintile of gestational weight gain (GWG) rate
Number of subjects: 13765
Study: 35650639

Group type: EXPERIMENTAL
Intervention: Zibotentan
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34397821

Group type: EXPERIMENTAL
Intervention: Vitamin E (25 IU)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32038200

Group type: EXPERIMENTAL
Intervention: Interactive eye tracked virtual reality (VR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-interactive VR (passive)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interactive eye tracked VR
Number of subjects: 48
Study: 36055874

Group type: EXPERIMENTAL
Intervention: 20 μg FMP013 / 0.5 mL ALFQ (Low dose group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 40 μg FMP013 / 1.0 mL ALFQ (High dose group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Historical responses reported for RTS,S/AS01
Number of subjects: 10
Study: 34658151

Group type: EXPERIMENTAL
Intervention: Pulsed Nd:YAG laser and intralesional bleomycin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pulsed Nd:YAG laser only
Number of subjects: 40
Study: 36125053

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (2g daily for 6 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study: 32522363

Group type: COMPARATOR
Intervention: 2-mm ferrule restoration (NPR2; control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.5×0.5-mm ISRF (ISRF0.5)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2-mm CLP (CLP2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2-mm OEP (OEP2)
Number of subjects: 32
Study: 35169169

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (200 mL single transfusion)
Number of subjects: 103

Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo)
Number of subjects: 103
Study: 33639024

Group type: EXPERIMENTAL
Intervention: Transformational leadership
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Emotional intelligence
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Overall level of workplace social capital
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Overall level of emotional intelligence
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Overall level of organizational justice
Number of subjects: 344
Study: 32134882

Group type: EXPERIMENTAL
Intervention: PowerPoint-based e-CBT delivered via email (12 weekly modules and homework assignments)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80
Study: 35973787

Group type: EXPERIMENTAL
Intervention: FMT and anti-inflammatory diet (FMT-AID)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Anti-inflammatory diet alone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Optimised standard medical therapy (SMT)
Number of subjects: 66
Study: 33497375

Group type: EXPERIMENTAL
Intervention: 10% w/w metofluthrin emanators
Number of subjects: 200
Study: 32735053

Group type: EXPERIMENTAL
Intervention: 16-week smartphone-based aftercare intervention with therapist feedback as add-on to treatment as usual (TAU)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 186
Study: 35848060

Group type: EXPERIMENTAL
Intervention: Modified video-feedback parenting intervention delivered in-home by trained mental health professionals over 4-6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 33258495

Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine showers and mupirocin nasal ointment twice a day for 5 days before surgery (S. aureus carrier group)
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine showers (noncarrier group)
Number of subjects: 613
Study: 33105701

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) for 4 weeks, eating window limited to 10:00 - 19:00 h
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) adherence
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 19
Study: 35332853

Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment (NPA) with feedback
Number of subjects: 71

Group type: COMPARATOR
Intervention: Delayed-treatment control group
Number of subjects: 71
Study: 34248926

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0
Study: 32475445

Group type: COMPARATOR
Intervention: Fast-growing strain (B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Slow-growing strains (D, H, M)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Slow-growing strain (E)
Number of subjects: 100
Study: 36347059

Group type: EXPERIMENTAL
Intervention: Oral combination regimen (bedaquiline, pretomanid, linezolid, moxifloxacin) for 24 weeks
Number of subjects: 4446

Group type: COMPARATOR
Intervention: Early treatment of anal high-grade squamous intraepithelial lesions
Number of subjects: 4446
Study: 32692300

Group type: EXPERIMENTAL
Intervention: Deep Learning-based Automatic Detection Algorithm (DLAD)
Number of subjects: 117

Group type: COMPARATOR
Intervention: No DLAD
Number of subjects: 117
Study: 36222612

Group type: EXPERIMENTAL
Intervention: Acute head-neck cooling for ≥45 minutes in addition to standard SRC management
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard SRC management (control group)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Acute head-neck cooling
Number of subjects: 132
Study: 34491013

Group type: EXPERIMENTAL
Intervention: Modified Stamp Technique (MST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Technique (CT)
Number of subjects: 30
Study: 32696227

Group type: EXPERIMENTAL
Intervention: Intravenous 5% dextrose in 0.9% normal saline (according to weight-based maintenance rate)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Dexamethasone (0.15 mg·kg−1 iv) and ondansetron (0.05 mg·kg−1 iv)
Number of subjects: 290
Study: 36213959

Group type: EXPERIMENTAL
Intervention: Home-based care with community and primary healthcare workers' support
Number of subjects: 240

Group type: COMPARATOR
Intervention: Routine clinic-based care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Home-based care and Routine clinic-based care
Number of subjects: 240
Study: 34218513

Group type: EXPERIMENTAL
Intervention: PERN facilitated international collaborative research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PERN's network infrastructure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PERN's goals
Number of subjects: 0
Study: 32829943

Group type: EXPERIMENTAL
Intervention: Home kinematic training (KT) for 4 weeks using laser or virtual reality
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Home kinematic training (KT)
Number of subjects: 79
Study: 35386725

Group type: EXPERIMENTAL
Intervention: ANGEL-6000 EEG depth monitor
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard anesthetic monitoring)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups received the same anesthetic drugs
Number of subjects: 60
Study: 34224519

Group type: EXPERIMENTAL
Intervention: Lateral decubitus position
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 28
Study: 33825118

Group type: EXPERIMENTAL
Intervention: Freeze-only strategy with subsequent frozen embryo transfer (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fresh embryo transfer (n = 20)
Number of subjects: 40
Study: 32126977

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg oral daily for 6 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: IFN-β 1b 250 μg subcutaneous every other day for 6 months
Number of subjects: 15
Study: 34371162

Group type: EXPERIMENTAL
Intervention: Active Living Every Day (ALED) and age-relevant health education information
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: ALED program in combination with Our Voice (neighborhood-level citizen science intervention)
Number of subjects: 300
Study: 32077891

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks) starting 2 to 6 weeks after chemoradiotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (100 mg IV every 3 weeks) starting day 29 of chemoradiotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks) starting day 29 of chemoradiotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (100 mg IV every 3 weeks) starting day 1 of chemoradiotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks) starting day 1 of chemoradiotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Safety expansion cohort with cohort 5 regimen
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (at least 1 dose)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (at least 2 doses)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Immune-related adverse events
Number of subjects: 21
Study: 33337437

Group type: EXPERIMENTAL
Intervention: Foot reflexology intervention
Number of subjects: 256
Study: 32199184

Group type: EXPERIMENTAL
Intervention: Social Skills Training (SST)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 36169496

Group type: EXPERIMENTAL
Intervention: Early piezocision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Late piezocision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 40

Group type: COMPARATOR
Intervention: No piezocision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Piezocision (early and late)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 40
Study: 33891230

Group type: EXPERIMENTAL
Intervention: saccharide preload (26 kcal)
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo capsules
Number of subjects: 17
Study: 35468266

Group type: EXPERIMENTAL
Intervention: Group-based outpatient physical therapy intervention delivered six weeks after TKR.
Number of subjects: 180
Study: 33999707

Group type: EXPERIMENTAL
Intervention: 5 mg dronabinol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32134802

Group type: EXPERIMENTAL
Intervention: Brimo DDS 132 µg
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Brimo DDS 264 µg
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Brimo DDS 132 µg and 264 µg
Number of subjects: 113
Study: 35857131

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg kg−1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32816639

Group type: EXPERIMENTAL
Intervention: Buspirone (7.5-15 mg twice daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Trazodone (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 35822542

Group type: EXPERIMENTAL
Intervention: High aerobic exercise-induced energy expenditures in energy balance (BAL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High aerobic exercise-induced energy expenditures in energy deficit (DEF)
Number of subjects: 10
Study: 34738909

Group type: EXPERIMENTAL
Intervention: Foot reflexology (30 minutes each session)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (conventional care without foot reflexology)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 80
Study: 33118401

Group type: EXPERIMENTAL
Intervention: Peppermint extract (40 drops mixed in 20 cc of tap water every 8 hours)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Distilled water (40 drops mixed in 20 cc of tap water every 8 hours)
Number of subjects: 84
Study: 36125472

Group type: EXPERIMENTAL
Intervention: Roflumilast cream, 0.3%
Number of subjects: 881
Study: 32363765

Group type: EXPERIMENTAL
Intervention: Immediate Loading (IML)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional Loading (CL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both IML and CL
Number of subjects: 20
Study: 36134506

Group type: EXPERIMENTAL
Intervention: Guar fortified breads with galactomannan above coil overlap
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Guar fortified breads with galactomannan below coil overlap
Number of subjects: 12

Group type: COMPARATOR
Intervention: Wheat flour control bread
Number of subjects: 12
Study: 33653385

Group type: EXPERIMENTAL
Intervention: Community-based intervention including identification and screening of household contacts, referral of contacts with TB-suggestive symptoms, and household initiation of preventive therapy.
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Facility-based standard of care arm.
Number of subjects: 1500
Study: 36209981

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with gemcitabine (1000mg/m2) and nab-Paclitaxel (125mg/m2) for 2 preoperative and 4 postoperative cycles (arm A)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with gemcitabine (1000mg/m2) and nab-Paclitaxel (125mg/m2) for 6 cycles (arm B)
Number of subjects: 127
Study: 33813638

Group type: EXPERIMENTAL
Intervention: Combined Nd:YAG/Er:YAG laser therapy (test group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Turned off laser therapy (control group)
Number of subjects: 22
Study: 36207993

Group type: EXPERIMENTAL
Intervention: Oscillating chitosan brush (OCB)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Titanium curettes (TC)
Number of subjects: 39
Study: 33454262

Group type: EXPERIMENTAL
Intervention: Coronary artery calcium (CAC) scoring strategy
Number of subjects: 1083

Group type: COMPARATOR
Intervention: Traditional risk factor-based prediction
Number of subjects: 1083
Study: 33260151

Group type: COMPARATOR
Intervention: rTMS (repetitive transcranial magnetic stimulation)
Number of subjects: 0
Study: 35391634

Group type: EXPERIMENTAL
Intervention: Heat‐ and moisture‐exchanging breathing device (HME)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No HME
Number of subjects: 23
Study: 33124016

Group type: EXPERIMENTAL
Intervention: Normal mouthguard
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mouthguard with breathing channels
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no mouthguard)
Number of subjects: 13
Study: 33220702

Group type: EXPERIMENTAL
Intervention: MRI assessments based on PsAMRIS for heel enthesitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modifications to PsAMRIS scoring system
Number of subjects: 0